Catalyst Wire Dossier Catalyst Wire Dossier

Empagliflozin / Linagliptin fixed-dose combination

empagliflozin/linagliptin · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Empagliflozin / Linagliptin fixed-dose combination, covering 2015-04-02 to 2018-08-16. Get the full timeline:

Most recent: Clinical Trial Update: Empa/Lina FDC Food Effect Study (Japan) [Phase 1]

See pricing